UK markets close in 1 hour 55 minutes

ProMIS Neurosciences, Inc. (PMN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.9246-0.0604 (-3.04%)
As of 04:00PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 36.49M
Enterprise value 26.75M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)9.72
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.06

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 3-68.73%
S&P500 52-week change 325.59%
52-week high 38.9500
52-week low 30.9500
50-day moving average 32.0350
200-day moving average 31.8989

Share statistics

Avg vol (3-month) 316.82k
Avg vol (10-day) 36.74k
Shares outstanding 518.96M
Implied shares outstanding 618.96M
Float 811M
% held by insiders 124.33%
% held by institutions 117.88%
Shares short (15 Apr 2024) 423.05k
Short ratio (15 Apr 2024) 41.43
Short % of float (15 Apr 2024) 40.16%
Short % of shares outstanding (15 Apr 2024) 40.12%
Shares short (prior month 15 Mar 2024) 424.03k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:60
Last split date 328 Jun 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-81.92%
Return on equity (ttm)-1,098.51%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -13.44M
Net income avi to common (ttm)-13.21M
Diluted EPS (ttm)-1.0700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.64M
Total cash per share (mrq)0.67
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)1.46
Book value per share (mrq)0.20

Cash flow statement

Operating cash flow (ttm)-10.84M
Levered free cash flow (ttm)-5.3M